- Oral presentation
- Open Access
Statistical challenges in assessing potential efficacy of complex interventions in pilot or feasibility studies
© Wilson et al. 2015
Published: 16 November 2015
Early phase trials of complex interventions currently focus on assessing the feasibility of a confirmatory RCT and on conducting pilot work. These trials are not designed to enable a formal assessment of potential efficacy. As a result, guidance recommends any statistical analysis of treatment effects conducted in these trials should be treated with extreme caution and not used in deciding if a confirmatory trial of the intervention is warranted. Phase II trial designs developed in the drug context offer a potential solution, providing methods for selecting sample size parameters for feasibility and pilot trials which will enable formal assessments of potential efficacy to be carried out. In this paper we will outline the challenges encountered in extending ideas developed in the phase II drug trial literature to the complex intervention setting. The prevalence of multiple endpoints and clustering of outcome data will be identified as important considerations, having implications for timely and robust determination of optimal sample size parameters. The potential for Bayesian methods to help to identify robust trial designs and optimal decision rules will also be explored.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.